BIO-key bottom line rises 51% on 13% Q2 revenue increase
BIO-key (BKYI) reports its bottom line improves 51% alongside a 13% rise in Q2 revenues, citing strength with government, defense, and financial sector customers globally.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.